Where is ESSA headquartered?

ESSA is located in Vancouver, british columbia.

Who invested in ESSA?

ESSA has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for ESSA?

ESSA closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

essapharma.com

ESSA

ESSA is a Canada-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of prostate cancer.

Business Model:

Revenue: $8.8M

Employees: 11-50

Geographic Data

Address: 999 West Broadway

City: Vancouver

State: british columbia

Zip: V5Z 1K5

Country: CA

Financial Info

Stage:

post ipo equity

Raised Last:

$14M

Raised Total:

$228M

Social

Twitter

Crunchbase

Metrics

8,755,999Website Global Rank

261Website Monthly Traffic

Twitter Followers

Description

ESSA is a Canada-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of prostate cancer.

Contact Phone:
+17783310962

Contact Email:

IPO Details

ESSA went public on 7/17/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/17/2015

Ticker Symbol:
EPIX

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2021	Post-IPO Equity	1	$10M	Pfizer Breakthrough Growth Initiative Pfizer Breakthrough Growth Initiative
8/2020	Post-IPO Equity		$0	Vivo Capital CAM Capital Avidity Partners Ridgeback Capital Sphera Global Healthcare Fund Pfizer Point72 BVF Partners Vivo Capital CAM Capital Avidity Partners Ridgeback Capital Sphera Global Healthcare Fund Pfizer Point72 BVF Partners
1/2018	Post-IPO Equity	1	$5M	Omega Funds Omega Funds
8/2019	Post-IPO Equity		$36M
4/2017	Grant	1	$5.2M	Cancer Prevention and Research Institute of Texas Cancer Prevention and Research Institute of Texas
7/2022	Post-IPO Equity		$11.5M	BVF Partners L.P.
7/2022	Post-IPO Equity		$2.1M	BVF Partners L.P.
7/2022	Post-IPO Equity	1	$13.6M	BVF Partners BVF Partners
2/2021	Post-IPO Equity	1	$130M	Frazier Healthcare Partners Frazier Healthcare Partners
11/2016	Post-IPO Debt	1	$10M	Silicon Valley Bank Silicon Valley Bank
1/2016	Post-IPO Equity	2	$15M	Clarus Ventures Deepfield Clarus Ventures
7/2022	Post-IPO Equity	1	$13.6M	BVF Partners BVF Partners
8/2020	Post-IPO Equity	8	$55.9M	Vivo Capital CAM Capital Avidity Partners Ridgeback Capital Sphera Global Healthcare Fund Pfizer Point72 BVF Partners Vivo Capital CAM Capital Avidity Partners Ridgeback Capital Sphera Global Healthcare Fund Pfizer Point72 BVF Partners

Acquisitions

Announced Date	Name	Price
5/2019	Realm Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details